AstraZeneca Pharma India Q1 2026: Strong Growth and Resilience Astrazeneca Pharma India posts impressive Q1 2026 results with robust revenue growth, disciplined operations, and new oncology launches. A Strong Start: Q1 2026 Overview Astrazeneca Pharma India opened the fiscal year … Continue reading AstraZeneca Pharma India Q1 2026: Strong Growth and Resilience